WHO ICTRP trial
Comparison of retrograde and spot botulinium toxin injection in the treatment of…
ChiCTR2100046880 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046880 |
|---|---|
| Public title | Comparison of retrograde and spot botulinium toxin injection in the treatment of forehead, glabellar, and periorbital wrinkles: a prospective, single-blind, randomized clinical trial |
| Scientific title | Comparison of retrograde and spot botulinium toxin injection in the treatment of forehead, glabellar, and periorbital wrinkles: a prospective, single-blind, randomized clinical trial |
| Primary sponsor | Peking Union Medical College Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Interventions | Group 1:Linear injection on one side;Group 2:One side spot injection |
| Registration date | May 29, 2021 |
| Target size | Group 1:30;Group 2:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: